Results 211 to 220 of about 18,976,803 (305)
Correction: A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma. [PDF]
Xiao Y +7 more
europepmc +1 more source
In MYC‐enforced B‐cell lymphoma, SOX5 occupies promoter‐proximal regulatory regions and is associated with reduced chromatin accessibility at the PCNP locus. PCNP repression promotes proliferative remodeling by limiting apoptosis and cell‐cycle restraint.
Yiyou Mao +6 more
wiley +1 more source
Involvement of c-Myc/WWP1/TRIM65 Axis in Renal Fibrosis. [PDF]
Mazumder S +7 more
europepmc +1 more source
Programmable Nanobody‐Targeting Chimeras Enable Intracellular Viral Protein Degradation
Nab‐TAC enables targeted degradation of HBV surface antigen (HBsAg) in vivo. By fusing nanobody‐based recognition domains with programmable proteasome‐recruiting degradation signals, Nab‐TAC reduces HBsAg levels in a hydrodynamic HBV mouse model. ABSTRACT Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because
Max Yu‐Chen Pan +11 more
wiley +1 more source
Down-regulation of THBS2 inhibits the malignant progression of Burkitt lymphoma by blocking the PI3K/AKT/c-MYC pathway. [PDF]
Xu Y, Liu S, Wang S, Huang Y.
europepmc +1 more source
In PWS‐ASPCs, FOSL1 drives the expression of SPSB1. SPSB1, as part of the ESC complex, further binds to HDAC1 and promotes K29‐linked and K48‐linked polyubiquitination of HDAC1. These modifications facilitate the degradation of HDAC1 through the ALP and UPS pathways, respectively.
Hongrui Chen +5 more
wiley +1 more source
CDC20 promotes prostate cancer progression via modulating c-MYC and PI3K-AKT signaling. [PDF]
Ding J +9 more
europepmc +1 more source
In this work, we design an ultrasound‐activated piezoelectric hydrogel platform (AOEF@AP5+US) that reprograms neurogenesis‐macrophage crosstalk as an integrated strategy to overcome the intertwined barriers of chronic inflammation, peripheral neuropathy, and impaired regeneration in diabetic wounds.
Kai Wang +13 more
wiley +1 more source
2-O-Methylmagnolol suppresses oral squamous cell carcinoma progression by targeting c-MYC signaling. [PDF]
Chen CY +10 more
europepmc +1 more source

